[1] 麻勇,姜洪池.肝脏缺血再灌注损伤的实验研究现状与展望[J].中华实验外科杂志,2012,29(10):1880-1882. [2] ABUAMARA W,YANG S Y,TAPURIA N,et al. Liver ischemia/reperfusion injury:Processes in inflammatory networks-a review[J]. Liver Transplant, 2010, 16(9):1016-1032. [3] 岳媛媛, 冯志杰. 肝脏缺血再灌注损伤与钙超载[J]. 世界华人消化杂志, 2008, 16(32):3654-3658. [4] 廖美娟,梁桦,梁幸甜, 等.姜黄素抑制诱导型一氧化氮合酶活性减轻大鼠肠缺血再灌注损伤[J].实用医学杂志,2015,31(20):3302-3303. [5] SHUKLA P K, KHANNA V K,ALI M M, et al. Anti-ischemic effect of curcumin in rat brains[J].Neurochem Res,2008,33(6):1036-1043. [6] 刘莉,谭波涛,李昱,等.姜黄素对大鼠大脑皮质缺血再灌注损伤的保护作用及其机制研究[J].解放军医学杂志,2013,38(3):190-194. [7] 李明芬.姜黄素对缺血再灌注损伤器官的保护作用[J].海峡药学,2016,28(2):139-141. [8] 李彩新,张永强,王丹,等.姜黄素和东莨菪内酯对朱砂叶螨形态变化和水分损失的影响[J].西南大学学报(自然科学版), 2017,39(11):10-15. [9] 陈思砚,潘静,陈生弟.姜黄素在神经系统疾病治疗中的应用[J].上海交通大学学报(医学版),2010,30(6):732-734,741. [10] 臧卫周,杨红旗,徐军,等.姜黄素对缺氧复氧损伤PC12细胞的影响[J].郑州大学学报(医学版),2009, 44(3):594-596. [11] 成扬,平键,徐列明,等.姜黄素上调PPAR抑制肝星状细胞活化标志表达的研究[J].中国实用内科杂志,2006,26(24):1937-1940. [12] NIEUWENHUIJS V B, DE BRUIJN M T, SCHIESSER M, et al. Ischemic preconditioning and intermittent ischemia preserve bile flow in a rat model of ischemia/reperfusion injury[J]. Dig Dis Sci, 2007, 52(11):3029-3037. [13] ZHAO Q H, HAN F, WU K, et al. Protective effects of apoptosis of kupffer cells induced by zoledronate liposomes following hepatic ischemia-reperfusion injury[J]. Ann Transplant,2018, 23:815-821. [14] AKHTAR M Z, HENDERSON T, SUTHERLAND A, et al. Novel approaches to preventingischemia-reperfusion injury during liver transplantation[J]. Transplant Proc, 2013,45(6):2083-2092. [15] 赵秀峰,常超,信栓力,等.姜黄素在大鼠心肌缺血再灌注中的作用研究[J].中西医结合心脑血管病杂志,2010, 8(8):956. [16] GHOSH N, GHOSH R,MANDAL V, et al. Recent advances in herbal medicine for treatment of liver diseases[J]. Pharm Biol, 2011, 49(9):970-988. [17] USTUN Y B,KOKSAL E,KAYA C, et al. The effects of dexketoprofen on endogenous leptin and lipid peroxidation during liver ischemia reperfusion injury[J]. Int Surg, 2014, 99(6):757-763. [18] 冯敬媛,李舒承,王虹,等.姜黄素对慢性心力衰竭大鼠肾素-血管紧张素-醛固酮系统和心功能的改善作用[J].吉林大学学报(医学版),2019,45(2):325-330. [19] 许东亮,彭朝晖,熊美才.姜黄素对骨质疏松大鼠种植体骨结合的促进作用[J].吉林大学学报(医学版),2019,45(4):877-881,987. [20] RAVINDRANATH V, CHANDRASEKHARA N. In vitro studies on the intestinal absorption of curcumin in rats[J]. Toxicology, 1981, 20(2/3):251-257. [21] RAVINDRANATH V, CHANDRASEKHARA N. Metabolism of curcumin-studies with[3H]curcumin[J]. Toxicology, 1981, 22(4):337-344. [22] YANG K Y, LIN L C, TSENG T Y, et al. Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2007, 853(1/2):183-189. [23] XU X Y,MENG X,LI S, et al. Bioactivity, health benefits, and related molecular mechanisms of curcumin:current progress, challenges, and perspectives[J]. Nutrients,2018,10(10):E1553. [24] RAO E V, SUDHEER P. Revisiting curcumin chemistry part Ⅰ:A new strategy for the synthesis of curcuminoids[J].Indian J Pharm Sci,2011, 73(3):262-270. [25] 王鲁慧,徐同成,刘丽娜,等.羧甲基纤维素钠对番茄红素复凝聚微胶囊性能的影响[J].食品科学,2018,39(1):105-110. [26] JOSHI R P, NEGI G, KUMAR A, et al. SNEDDS curcumin formulation leads to enhanced protection from pain and functional deficits associated with diabetic neuropathy:an insight into its mechanism for neuroprotection[J]. Nanomed-Nanotechnol Biol Med, 2013, 9(6):776-785. |